Regulatory tool
China cosmetic ingredient inventory search
Brazil follows the MERCOSUR technical framework; prohibitions and restrictions are issued as RDC resolutions that reference the MERCOSUR common lists. Transcribed from third-party legal databases (LegisWeb, Cosmetoguia): prohibited list = RDC 83/2016 annex plus the 8 substances added by RDC 529/2021; restricted list and fragrance allergens from RDC 530/2021; preservatives RDC 528/2021; UV filters RDC 600/2022. The colorant list (RDC 628/2022) is not yet included (scanned copies only). The ANVISA / DOU text prevails. Transcribed from third-party legal databases (LegisWeb, Cosmetoguia): prohibited list = RDC 83/2016 annex plus the 8 substances added by RDC 529/2021; restricted list and fragrance allergens from RDC 530/2021; preservatives RDC 528/2021; UV filters RDC 600/2022. The colorant list (RDC 628/2022) is not yet included (scanned copies only). The ANVISA / DOU text prevails.
Ang paghahanap ay para lamang sa Tsino at Ingles — gumamit ng terminong Ingles o pangalang INCI.
1,595 entries
| ID | Chemical name / description | INCI name | CAS No. | Function · Annex · Limit |
|---|---|---|---|---|
| BR-83/237 | Tefazolina* e seus saisformer name:237 | Tefazolina* e seus sais | 1082-56-0 | 禁用 · RDC 83/2016 附件第 237 项(GMC 62/14) · 欧盟附录 II 序号 237 |
| BR-83/238 | Arecolinaformer name:238 | Arecolina | 63-75-2 | 禁用 · RDC 83/2016 附件第 238 项(GMC 62/14) · 欧盟附录 II 序号 238 · EC 200-565-5 |
| BR-83/239 | Metilsulfato de Poldina*former name:239 | Metilsulfato de Poldina* | 545-80-2 | 禁用 · RDC 83/2016 附件第 239 项(GMC 62/14) · 欧盟附录 II 序号 239 · EC 208-894-6 |
| BR-83/24 | Zoxazolamina*former name:24 | Zoxazolamina* | 61-80-3 | 禁用 · RDC 83/2016 附件第 24 项(GMC 62/14) · 欧盟附录 II 序号 24 · EC 200-519-4 |
| BR-83/240 | Hidroxizina*former name:240 | Hidroxizina* | 68-88-2 | 禁用 · RDC 83/2016 附件第 240 项(GMC 62/14) · 欧盟附录 II 序号 240 · EC 200-693-1 |
| BR-83/241 | 2 Naftolformer name:241 | 2 Naftol | 135-19-3 | 禁用 · RDC 83/2016 附件第 241 项(GMC 62/14) · 欧盟附录 II 序号 241 · EC 205-182-7 |
| BR-83/242 | 1 e 2 Naftilaminas e seus saisformer name:242 | 1 e 2 Naftilaminas e seus sais | 134-32-7/91-59-8 | 禁用 · RDC 83/2016 附件第 242 项(GMC 62/14) · 欧盟附录 II 序号 242 |
| BR-83/243 | 3 (1 Naftil) 4 hidroxicumarinaformer name:243 | 3 (1 Naftil) 4 hidroxicumarina | 39923-41-6 | 禁用 · RDC 83/2016 附件第 243 项(GMC 62/14) · 欧盟附录 II 序号 243 |
| BR-83/244 | Nafazolina* e seus saisformer name:244 | Nafazolina* e seus sais | 835-31-4 | 禁用 · RDC 83/2016 附件第 244 项(GMC 62/14) · 欧盟附录 II 序号 244 · EC 212-641-5 |
| BR-83/245 | Neoestigmina e seus sais, por exemplo brometo de neoestigmina*former name:245 | Neoestigmina e seus sais, por exemplo brometo de neoestigmina* | 114-80-7 | 禁用 · RDC 83/2016 附件第 245 项(GMC 62/14) · 欧盟附录 II 序号 245 · EC 204-054-8 |
| BR-83/246 | Nicotina e seus saisformer name:246 | Nicotina e seus sais | 54-11-5 | 禁用 · RDC 83/2016 附件第 246 项(GMC 62/14) · 欧盟附录 II 序号 246 · EC 200-193-3 |
| BR-83/247 | Nitritos de Amilaformer name:247 | Nitritos de Amila | 110-46-3 | 禁用 · RDC 83/2016 附件第 247 项(GMC 62/14) · 欧盟附录 II 序号 247 · EC 203-770-8 |
| BR-83/248 | Nitritos Inorgânicos, com exceção do Nitrito de Sódioformer name:248 | Nitritos Inorgânicos, com exceção do Nitrito de Sódio | 14797-65-0 | 禁用 · RDC 83/2016 附件第 248 项(GMC 62/14) · 欧盟附录 II 序号 248 |
| BR-83/249 | Nitrobenzenoformer name:249 | Nitrobenzeno | 98-95-3 | 禁用 · RDC 83/2016 附件第 249 项(GMC 62/14) · 欧盟附录 II 序号 249 · EC 202-716-0 |
| BR-83/25 | Procainamida*, seus sais e seus derivadosformer name:25 | Procainamida*, seus sais e seus derivados | 51-06-9 | 禁用 · RDC 83/2016 附件第 25 项(GMC 62/14) · 欧盟附录 II 序号 25 · EC 200-078-8 |
| BR-83/250 | Nitrocresóis e seus sais de metais alcalinosformer name:250 | Nitrocresóis e seus sais de metais alcalinos | 12167-20-3 | 禁用 · RDC 83/2016 附件第 250 项(GMC 62/14) · 欧盟附录 II 序号 250 |
| BR-83/251 | Nitrofurantoína*former name:251 | Nitrofurantoína* | 67-20-9 | 禁用 · RDC 83/2016 附件第 251 项(GMC 62/14) · 欧盟附录 II 序号 251 · EC 200-646-5 |
| BR-83/252 | Furazolidona*former name:252 | Furazolidona* | 67-45-8 | 禁用 · RDC 83/2016 附件第 252 项(GMC 62/14) · 欧盟附录 II 序号 252 · EC 200-653-3 |
| BR-83/253 | Nitroglicerinaformer name:253 | Nitroglicerina | 55-63-0 | 禁用 · RDC 83/2016 附件第 253 项(GMC 62/14) · 欧盟附录 II 序号 253 · EC 200-240-8 |
| BR-83/254 | Acenocumarol*former name:254 | Acenocumarol* | 152-72-7 | 禁用 · RDC 83/2016 附件第 254 项(GMC 62/14) · 欧盟附录 II 序号 254 · EC 205-807-3 |
| BR-83/255 | Ferrato alcalino de Pentacianonitrosilo (2-) ( Nitroprussiatos )former name:255 | Ferrato alcalino de Pentacianonitrosilo (2-) ( Nitroprussiatos ) | 14402-89-2/13755-38-9 | 禁用 · RDC 83/2016 附件第 255 项(GMC 62/14) · 欧盟附录 II 序号 255 · EC 238-373-9 |
| BR-83/256 | Nitrostilbenos, seus homólogos e seus derivadosformer name:256 | Nitrostilbenos, seus homólogos e seus derivados | 4003-94-5 | 禁用 · RDC 83/2016 附件第 256 项(GMC 62/14) · 欧盟附录 II 序号 256 · EC 223-653-5 |
| BR-83/257 | Noradrenalina e seus saisformer name:257 | Noradrenalina e seus sais | 51-41-2 | 禁用 · RDC 83/2016 附件第 257 项(GMC 62/14) · 欧盟附录 II 序号 257 · EC 200-096-6 |
| BR-83/258 | Noscapina* e seus saisformer name:258 | Noscapina* e seus sais | 128-62-1 | 禁用 · RDC 83/2016 附件第 258 项(GMC 62/14) · 欧盟附录 II 序号 258 · EC 204-899-2 |
| BR-83/259 | Guanetidina* e seus saisformer name:259 | Guanetidina* e seus sais | 55-65-2 | 禁用 · RDC 83/2016 附件第 259 项(GMC 62/14) · 欧盟附录 II 序号 259 · EC 200-241-3 |
| BR-83/26 | Benzidinaformer name:26 | Benzidina | 92-87-5 | 禁用 · RDC 83/2016 附件第 26 项(GMC 62/14) · 欧盟附录 II 序号 26 · EC 202-199-1 |
| BR-83/260 | Estrógenosformer name:260 | Estrógenos | — | 禁用 · RDC 83/2016 附件第 260 项(GMC 62/14) · 欧盟附录 II 序号 260 |
| BR-83/261 | Oleandrinaformer name:261 | Oleandrina | 465-16-7 | 禁用 · RDC 83/2016 附件第 261 项(GMC 62/14) · 欧盟附录 II 序号 261 · EC 207-361-5 |
| BR-83/262 | Clortalidona*former name:262 | Clortalidona* | 77-36-1 | 禁用 · RDC 83/2016 附件第 262 项(GMC 62/14) · 欧盟附录 II 序号 262 · EC 201-022-5 |
| BR-83/263 | Peletierina e seus saisformer name:263 | Peletierina e seus sais | 2858-66-4/4396-01-4 | 禁用 · RDC 83/2016 附件第 263 项(GMC 62/14) · 欧盟附录 II 序号 263 |
| BR-83/264 | Pentacloroetanoformer name:264 | Pentacloroetano | 76-01-7 | 禁用 · RDC 83/2016 附件第 264 项(GMC 62/14) · 欧盟附录 II 序号 264 · EC 200-925-1 |
| BR-83/265 | Tetranitrato de Pentaeritritila*former name:265 | Tetranitrato de Pentaeritritila* | 78-11-5 | 禁用 · RDC 83/2016 附件第 265 项(GMC 62/14) · 欧盟附录 II 序号 265 · EC 201-084-3 |
| BR-83/266 | Petricloral*former name:266 | Petricloral* | 78-12-6 | 禁用 · RDC 83/2016 附件第 266 项(GMC 62/14) · 欧盟附录 II 序号 266 |
| BR-83/267 | Octamilamina* e seus saisformer name:267 | Octamilamina* e seus sais | 502-59-0 | 禁用 · RDC 83/2016 附件第 267 项(GMC 62/14) · 欧盟附录 II 序号 267 · EC 207-947-0 |
| BR-83/268 | Ácido Pícricoformer name:268 | Ácido Pícrico | 88-89-1 | 禁用 · RDC 83/2016 附件第 268 项(GMC 62/14) · 欧盟附录 II 序号 268 · EC 201-865-9 |
| BR-83/269 | Fenacemida*former name:269 | Fenacemida* | 63-98-9 | 禁用 · RDC 83/2016 附件第 269 项(GMC 62/14) · 欧盟附录 II 序号 269 · EC 200-570-2 |
| BR-83/27 | Tuaminoheptano*, seus isômeros e seus saisformer name:27 | Tuaminoheptano*, seus isômeros e seus sais | 123-82-0 | 禁用 · RDC 83/2016 附件第 27 项(GMC 62/14) · 欧盟附录 II 序号 27 · EC 204-655-5 |
| BR-83/270 | Difencloxazina*former name:270 | Difencloxazina* | 5617-26-5 | 禁用 · RDC 83/2016 附件第 270 项(GMC 62/14) · 欧盟附录 II 序号 270 |
| BR-83/271 | 2 fenilindano 1, 3 diona (fenindiona)former name:271 | 2 fenilindano 1, 3 diona (fenindiona) | 83-12-5 | 禁用 · RDC 83/2016 附件第 271 项(GMC 62/14) · 欧盟附录 II 序号 271 · EC 201-454-4 |
| BR-83/272 | Etilfenacemida (feneturida)*former name:272 | Etilfenacemida (feneturida)* | 90-49-3 | 禁用 · RDC 83/2016 附件第 272 项(GMC 62/14) · 欧盟附录 II 序号 272 · EC 201-998-2 |
| BR-83/273 | Fenprocumona*former name:273 | Fenprocumona* | 435-97-2 | 禁用 · RDC 83/2016 附件第 273 项(GMC 62/14) · 欧盟附录 II 序号 273 · EC 207-108-9 |
| BR-83/274 | Feniramidol*former name:274 | Feniramidol* | 553-69-5 | 禁用 · RDC 83/2016 附件第 274 项(GMC 62/14) · 欧盟附录 II 序号 274 · EC 209-044-7 |
| BR-83/275 | Triamtereno* e seus saisformer name:275 | Triamtereno* e seus sais | 396-01-0 | 禁用 · RDC 83/2016 附件第 275 项(GMC 62/14) · 欧盟附录 II 序号 275 · EC 206-904-3 |
| BR-83/276 | Pirofosfato de Tetraetilaformer name:276 | Pirofosfato de Tetraetila | 107-49-3 | 禁用 · RDC 83/2016 附件第 276 项(GMC 62/14) · 欧盟附录 II 序号 276 · EC 203-495-3 |
| BR-83/277 | Fosfato de Tritolilaformer name:277 | Fosfato de Tritolila | 1330-78-5 | 禁用 · RDC 83/2016 附件第 277 项(GMC 62/14) · 欧盟附录 II 序号 277 · EC 215-548-8 |
| BR-83/278 | Psilocibina*former name:278 | Psilocibina* | 520-52-5 | 禁用 · RDC 83/2016 附件第 278 项(GMC 62/14) · 欧盟附录 II 序号 278 · EC 208-294-4 |
| BR-83/279 | Fósforo e fosfetos metálicosformer name:279 | Fósforo e fosfetos metálicos | 7723-14-0 | 禁用 · RDC 83/2016 附件第 279 项(GMC 62/14) · 欧盟附录 II 序号 279 · EC 231-768-7 |
| BR-83/28 | Octodrina* e seus saisformer name:28 | Octodrina* e seus sais | 543-82-8 | 禁用 · RDC 83/2016 附件第 28 项(GMC 62/14) · 欧盟附录 II 序号 28 · EC 208-851-1 |
| BR-83/280 | Talidomida* e seus saisformer name:280 | Talidomida* e seus sais | 50-35-1 | 禁用 · RDC 83/2016 附件第 280 项(GMC 62/14) · 欧盟附录 II 序号 280 · EC 200-031-1 |
| BR-83/281 | Physostigma venenosum Balf.former name:281 | Physostigma venenosum Balf. | 89958-15-6 | 禁用 · RDC 83/2016 附件第 281 项(GMC 62/14) · 欧盟附录 II 序号 281 · EC 289-638-0 |
Source: ANVISA. Reproduced from the official list without additions or changes. Listing is not approval; limits and conditions follow the latest official text.
Need to confirm whether an ingredient is usable in your target market? Send us the formulation direction.